Proficio Capital Partners LLC purchased a new position in AutoNation, Inc. (NYSE:AN – Free Report) in the fourth quarter, ...
Evercore ISI analyst Kirk Materne maintained a Buy rating on EverCommerce (EVCM – Research Report) on March 14 and set a price target of ...
Evercore ISI analyst Vedvati Shrotre reiterated a Buy rating on Nova (NVMI – Research Report) on March 14 and set a price target of $300.00.
Analysts at Zacks Research raised their Q1 2025 earnings estimates for CenterPoint Energy in a note issued to investors on ...
The Treasury secretary's muted reassurances to financial markets shows there may be no one in the administration willing to ...
We recently published a list of 12 AI Stocks Poised for Massive Growth. In this article, we are going to take a look at where ...
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...
DocuSign's AI-powered IAM product is driving rapid growth, cutting contract cycles by 75% & transforming agreement management ...
A very bullish analyst move was the news generally responsible for Summit Therapeutics ' ( SMMT -3.62%) healthy mid-week ...
One winning strategy from Trump's trade war is soaring right now: a pair trade that bets on stocks that thrive in an economy ...
ChatGPT's growth has soared, with 100 million new users in two months, making OpenAI a formidable competitor to Google in ...
4d
Fintel on MSNEvercore ISI Group Initiates Coverage of Summit Therapeutics (SMMT) with Outperform RecommendationFintel reports that on March 12, 2025, Evercore ISI Group initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Outperform recommendation. Analyst Price Forecast Suggests 90.91% Upside As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results